| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Crohn Disease | 40 | 2022 | 2295 | 2.730 |
Why?
|
| Colitis, Ulcerative | 28 | 2022 | 1926 | 2.390 |
Why?
|
| Gastroesophageal Reflux | 20 | 2022 | 836 | 2.320 |
Why?
|
| Inflammatory Bowel Diseases | 27 | 2021 | 2442 | 2.200 |
Why?
|
| Proton Pump Inhibitors | 7 | 2015 | 552 | 1.570 |
Why?
|
| Diacylglycerol O-Acyltransferase | 3 | 2024 | 21 | 1.190 |
Why?
|
| Intestinal Mucosa | 19 | 2019 | 3044 | 1.100 |
Why?
|
| Diarrhea | 7 | 2024 | 1320 | 1.090 |
Why?
|
| Mesalamine | 3 | 2018 | 134 | 1.040 |
Why?
|
| Gastroenterology | 10 | 2019 | 593 | 0.970 |
Why?
|
| Pediatrics | 13 | 2019 | 3629 | 0.850 |
Why?
|
| Gastrointestinal Diseases | 10 | 2019 | 1206 | 0.810 |
Why?
|
| 2-Pyridinylmethylsulfinylbenzimidazoles | 4 | 2010 | 32 | 0.700 |
Why?
|
| Child | 112 | 2024 | 80917 | 0.660 |
Why?
|
| Colon | 10 | 2018 | 1801 | 0.660 |
Why?
|
| Fungi | 3 | 2019 | 345 | 0.620 |
Why?
|
| Gastrointestinal Contents | 1 | 2018 | 42 | 0.620 |
Why?
|
| Feces | 8 | 2021 | 1511 | 0.600 |
Why?
|
| Autistic Disorder | 6 | 2022 | 1240 | 0.600 |
Why?
|
| Drug Substitution | 1 | 2021 | 291 | 0.600 |
Why?
|
| Sialyltransferases | 1 | 2018 | 83 | 0.590 |
Why?
|
| Constipation | 3 | 2013 | 570 | 0.560 |
Why?
|
| Proctocolectomy, Restorative | 5 | 2022 | 191 | 0.550 |
Why?
|
| Probiotics | 1 | 2020 | 387 | 0.510 |
Why?
|
| Intestine, Small | 6 | 2017 | 1217 | 0.480 |
Why?
|
| Anti-Inflammatory Agents | 9 | 2017 | 1805 | 0.480 |
Why?
|
| Child Development Disorders, Pervasive | 2 | 2010 | 598 | 0.480 |
Why?
|
| Infant | 62 | 2024 | 36535 | 0.470 |
Why?
|
| Gastrointestinal Agents | 7 | 2017 | 511 | 0.460 |
Why?
|
| C-Reactive Protein | 3 | 2018 | 3858 | 0.460 |
Why?
|
| Serotonin 5-HT4 Receptor Agonists | 1 | 2013 | 11 | 0.440 |
Why?
|
| Gastrointestinal Tract | 4 | 2019 | 840 | 0.440 |
Why?
|
| Benzofurans | 1 | 2013 | 138 | 0.410 |
Why?
|
| Laxatives | 1 | 2013 | 95 | 0.410 |
Why?
|
| Lymphoma | 2 | 2021 | 1898 | 0.410 |
Why?
|
| Transplantation | 1 | 2014 | 221 | 0.400 |
Why?
|
| Colonoscopy | 3 | 2017 | 1409 | 0.400 |
Why?
|
| Intestines | 9 | 2011 | 1909 | 0.400 |
Why?
|
| Defecation | 1 | 2013 | 191 | 0.390 |
Why?
|
| Tuberculosis, Gastrointestinal | 1 | 2011 | 20 | 0.390 |
Why?
|
| Child, Preschool | 59 | 2024 | 42669 | 0.390 |
Why?
|
| Adolescent | 78 | 2021 | 89169 | 0.380 |
Why?
|
| Health Records, Personal | 1 | 2012 | 127 | 0.370 |
Why?
|
| Gastrostomy | 1 | 2014 | 325 | 0.370 |
Why?
|
| Humans | 185 | 2024 | 768166 | 0.370 |
Why?
|
| Diagnostic Errors | 1 | 2018 | 1281 | 0.370 |
Why?
|
| Granuloma | 2 | 2012 | 329 | 0.360 |
Why?
|
| Biopsy | 10 | 2019 | 6793 | 0.350 |
Why?
|
| Peritoneum | 1 | 2011 | 230 | 0.350 |
Why?
|
| Cecum | 2 | 2010 | 231 | 0.340 |
Why?
|
| Cecal Diseases | 1 | 2010 | 49 | 0.340 |
Why?
|
| Research Report | 2 | 2012 | 369 | 0.340 |
Why?
|
| Anti-Ulcer Agents | 3 | 2007 | 112 | 0.330 |
Why?
|
| Male | 104 | 2024 | 364719 | 0.330 |
Why?
|
| Antibodies, Monoclonal | 10 | 2014 | 9263 | 0.320 |
Why?
|
| Peritonitis | 1 | 2011 | 368 | 0.320 |
Why?
|
| Appendix | 1 | 2010 | 110 | 0.320 |
Why?
|
| Child Welfare | 2 | 2012 | 523 | 0.310 |
Why?
|
| Intussusception | 1 | 2010 | 116 | 0.310 |
Why?
|
| Child Nutrition Disorders | 3 | 2010 | 140 | 0.310 |
Why?
|
| Health Surveys | 1 | 2019 | 4057 | 0.310 |
Why?
|
| Metagenome | 1 | 2012 | 465 | 0.310 |
Why?
|
| Congresses as Topic | 2 | 2018 | 812 | 0.310 |
Why?
|
| Abdominal Pain | 4 | 2011 | 1070 | 0.300 |
Why?
|
| Anal Canal | 4 | 2016 | 376 | 0.300 |
Why?
|
| Female | 103 | 2024 | 397192 | 0.300 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2014 | 2271 | 0.290 |
Why?
|
| Lymph Node Excision | 1 | 2014 | 1271 | 0.290 |
Why?
|
| Infant Formula | 1 | 2009 | 194 | 0.290 |
Why?
|
| Colectomy | 5 | 2021 | 696 | 0.290 |
Why?
|
| Duodenum | 3 | 2017 | 495 | 0.290 |
Why?
|
| Melanoma, Experimental | 3 | 2001 | 559 | 0.290 |
Why?
|
| Colitis | 5 | 2019 | 1242 | 0.280 |
Why?
|
| Clostridium Infections | 1 | 2014 | 562 | 0.280 |
Why?
|
| Intestinal Obstruction | 2 | 2010 | 433 | 0.270 |
Why?
|
| Double-Blind Method | 10 | 2015 | 12465 | 0.270 |
Why?
|
| Acquired Immunodeficiency Syndrome | 7 | 1996 | 2204 | 0.270 |
Why?
|
| Omeprazole | 2 | 2003 | 106 | 0.260 |
Why?
|
| Societies, Medical | 9 | 2018 | 3968 | 0.250 |
Why?
|
| Anti-Bacterial Agents | 4 | 2020 | 7477 | 0.250 |
Why?
|
| North America | 8 | 2019 | 1289 | 0.250 |
Why?
|
| Cooperative Behavior | 1 | 2012 | 1514 | 0.240 |
Why?
|
| Rectal Neoplasms | 1 | 2014 | 1183 | 0.240 |
Why?
|
| Endoscopy | 2 | 2019 | 1854 | 0.240 |
Why?
|
| Fellowships and Scholarships | 1 | 2014 | 1135 | 0.240 |
Why?
|
| Infant, Newborn | 29 | 2024 | 26422 | 0.240 |
Why?
|
| Occult Blood | 2 | 2016 | 199 | 0.230 |
Why?
|
| Awards and Prizes | 1 | 2009 | 365 | 0.230 |
Why?
|
| Gastric Acid | 2 | 2003 | 98 | 0.230 |
Why?
|
| Stomatitis, Aphthous | 2 | 2009 | 51 | 0.220 |
Why?
|
| Bacterial Typing Techniques | 2 | 2016 | 263 | 0.220 |
Why?
|
| Interleukin-10 Receptor alpha Subunit | 2 | 2021 | 29 | 0.220 |
Why?
|
| Physical Examination | 3 | 2016 | 1263 | 0.220 |
Why?
|
| Nutritional Physiological Phenomena | 3 | 2002 | 360 | 0.220 |
Why?
|
| Saudi Arabia | 3 | 2021 | 212 | 0.220 |
Why?
|
| Malabsorption Syndromes | 4 | 2002 | 135 | 0.210 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2024 | 304 | 0.210 |
Why?
|
| Genetic Variation | 1 | 2018 | 6611 | 0.210 |
Why?
|
| Callitrichinae | 3 | 1989 | 20 | 0.210 |
Why?
|
| Enteric Nervous System | 1 | 2006 | 213 | 0.210 |
Why?
|
| Esophagitis | 5 | 2007 | 164 | 0.210 |
Why?
|
| Failure to Thrive | 2 | 2021 | 139 | 0.200 |
Why?
|
| Lymph Nodes | 5 | 2021 | 3474 | 0.200 |
Why?
|
| Lung Neoplasms | 7 | 2021 | 13586 | 0.200 |
Why?
|
| Age of Onset | 5 | 2021 | 3347 | 0.200 |
Why?
|
| Immunologic Deficiency Syndromes | 3 | 2015 | 549 | 0.200 |
Why?
|
| Colonic Neoplasms | 1 | 2014 | 2541 | 0.200 |
Why?
|
| Weight Gain | 3 | 2009 | 2359 | 0.190 |
Why?
|
| Child Nutrition Sciences | 2 | 2018 | 22 | 0.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2021 | 4352 | 0.190 |
Why?
|
| Energy Intake | 1 | 2009 | 2146 | 0.190 |
Why?
|
| Homozygote | 2 | 2024 | 1779 | 0.190 |
Why?
|
| Colonic Pouches | 1 | 2022 | 122 | 0.180 |
Why?
|
| Secondary Prevention | 2 | 2017 | 1474 | 0.180 |
Why?
|
| Rectal Fistula | 1 | 2021 | 76 | 0.180 |
Why?
|
| Adoptive Transfer | 2 | 2000 | 825 | 0.180 |
Why?
|
| Cystic Fibrosis | 1 | 2010 | 1294 | 0.170 |
Why?
|
| Nerve Regeneration | 1 | 2006 | 797 | 0.170 |
Why?
|
| Allergy and Immunology | 1 | 2002 | 175 | 0.170 |
Why?
|
| Treatment Outcome | 21 | 2021 | 65371 | 0.170 |
Why?
|
| Pouchitis | 1 | 2020 | 64 | 0.170 |
Why?
|
| Food Hypersensitivity | 3 | 2010 | 734 | 0.170 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11878 | 0.170 |
Why?
|
| Adolescent Health Services | 1 | 2002 | 220 | 0.170 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2022 | 16045 | 0.170 |
Why?
|
| Digestive System | 2 | 1999 | 244 | 0.160 |
Why?
|
| Cancer Vaccines | 4 | 2001 | 1041 | 0.160 |
Why?
|
| Child Nutritional Physiological Phenomena | 4 | 2008 | 294 | 0.160 |
Why?
|
| Delivery of Health Care | 2 | 2016 | 5367 | 0.150 |
Why?
|
| Esophagitis, Peptic | 3 | 2011 | 77 | 0.150 |
Why?
|
| Fetus | 3 | 1999 | 1883 | 0.150 |
Why?
|
| Nutritional Support | 2 | 1998 | 178 | 0.150 |
Why?
|
| Gastroenteritis | 2 | 2012 | 235 | 0.150 |
Why?
|
| Case-Control Studies | 12 | 2018 | 22291 | 0.150 |
Why?
|
| Research | 4 | 2016 | 1979 | 0.150 |
Why?
|
| Gastrointestinal Motility | 3 | 2013 | 235 | 0.150 |
Why?
|
| Erythema Nodosum | 1 | 1998 | 32 | 0.150 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2021 | 5432 | 0.150 |
Why?
|
| Severity of Illness Index | 13 | 2019 | 15948 | 0.150 |
Why?
|
| Risk Reduction Behavior | 1 | 2004 | 1119 | 0.150 |
Why?
|
| Clinical Competence | 1 | 2014 | 4858 | 0.150 |
Why?
|
| Biological Transport, Active | 1 | 2018 | 323 | 0.150 |
Why?
|
| Dietary Proteins | 2 | 2002 | 960 | 0.150 |
Why?
|
| Pancreas | 3 | 2010 | 1700 | 0.140 |
Why?
|
| Biomedical Research | 2 | 2012 | 3463 | 0.140 |
Why?
|
| Interferon-gamma | 2 | 2008 | 3160 | 0.140 |
Why?
|
| B-Lymphocytes | 6 | 2013 | 4793 | 0.140 |
Why?
|
| Neuronal Plasticity | 1 | 2006 | 1448 | 0.140 |
Why?
|
| Remission Induction | 5 | 2014 | 2410 | 0.140 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2009 | 2185 | 0.140 |
Why?
|
| Celiac Disease | 3 | 2014 | 820 | 0.140 |
Why?
|
| Hair Diseases | 1 | 1997 | 72 | 0.140 |
Why?
|
| Dietary Carbohydrates | 1 | 2002 | 896 | 0.140 |
Why?
|
| Chemokine CCL11 | 2 | 2014 | 128 | 0.140 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2009 | 2171 | 0.140 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 2001 | 1801 | 0.140 |
Why?
|
| Retrospective Studies | 21 | 2024 | 81762 | 0.140 |
Why?
|
| Pyoderma Gangrenosum | 1 | 1998 | 84 | 0.140 |
Why?
|
| Databases, Factual | 1 | 2012 | 8080 | 0.130 |
Why?
|
| Peptide Hydrolases | 1 | 1999 | 610 | 0.130 |
Why?
|
| Duodenoscopy | 1 | 2016 | 45 | 0.130 |
Why?
|
| Dietary Fats | 1 | 2024 | 2003 | 0.130 |
Why?
|
| Immunosuppressive Agents | 5 | 2021 | 4206 | 0.130 |
Why?
|
| Administration, Oral | 5 | 2013 | 4030 | 0.130 |
Why?
|
| Intestinal Diseases | 4 | 2006 | 505 | 0.130 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2016 | 93 | 0.130 |
Why?
|
| Keratins | 1 | 1997 | 499 | 0.130 |
Why?
|
| Nutrition Disorders | 3 | 1998 | 204 | 0.130 |
Why?
|
| Young Adult | 12 | 2021 | 60066 | 0.130 |
Why?
|
| Lactoferrin | 1 | 2016 | 100 | 0.130 |
Why?
|
| Chemokine CXCL5 | 1 | 2015 | 27 | 0.130 |
Why?
|
| HIV Infections | 6 | 2009 | 17569 | 0.130 |
Why?
|
| Enzyme Inhibitors | 2 | 2003 | 3728 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2006 | 1662 | 0.120 |
Why?
|
| Saguinus | 2 | 1985 | 12 | 0.120 |
Why?
|
| Herpesvirus 4, Human | 1 | 2021 | 1082 | 0.120 |
Why?
|
| HIV-1 | 5 | 1994 | 6961 | 0.120 |
Why?
|
| Inflammation | 3 | 2021 | 10873 | 0.120 |
Why?
|
| Carbohydrate Metabolism | 2 | 2017 | 262 | 0.120 |
Why?
|
| Continuity of Patient Care | 1 | 2002 | 1078 | 0.120 |
Why?
|
| Glucocorticoids | 2 | 2019 | 2167 | 0.120 |
Why?
|
| Lactose Intolerance | 2 | 2011 | 28 | 0.120 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2018 | 888 | 0.120 |
Why?
|
| Rectum | 4 | 1994 | 900 | 0.120 |
Why?
|
| Esophagus | 6 | 1994 | 1042 | 0.120 |
Why?
|
| Autoantibodies | 2 | 1994 | 2121 | 0.110 |
Why?
|
| Adult | 38 | 2019 | 223646 | 0.110 |
Why?
|
| Fetal Tissue Transplantation | 2 | 1992 | 139 | 0.110 |
Why?
|
| Eosinophils | 2 | 2013 | 952 | 0.110 |
Why?
|
| Area Under Curve | 4 | 2013 | 1643 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 3814 | 0.110 |
Why?
|
| Matched-Pair Analysis | 1 | 2014 | 285 | 0.110 |
Why?
|
| Serum Albumin | 3 | 2012 | 677 | 0.110 |
Why?
|
| Esophagoscopy | 4 | 2006 | 398 | 0.110 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2017 | 271 | 0.110 |
Why?
|
| Interleukins | 1 | 1998 | 796 | 0.110 |
Why?
|
| Ribosome Subunits, Small | 1 | 2012 | 5 | 0.110 |
Why?
|
| Phylogeny | 2 | 2019 | 2843 | 0.110 |
Why?
|
| Tablets | 1 | 2013 | 149 | 0.100 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2014 | 166 | 0.100 |
Why?
|
| Europe | 5 | 2019 | 3436 | 0.100 |
Why?
|
| Quality of Life | 5 | 2021 | 13490 | 0.100 |
Why?
|
| Immune System | 1 | 1998 | 799 | 0.100 |
Why?
|
| Gastritis | 1 | 2014 | 199 | 0.100 |
Why?
|
| Colon, Transverse | 1 | 2012 | 25 | 0.100 |
Why?
|
| Domperidone | 1 | 1992 | 24 | 0.100 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2018 | 1120 | 0.100 |
Why?
|
| Diarrhea, Infantile | 1 | 2012 | 100 | 0.100 |
Why?
|
| Image Enhancement | 2 | 2019 | 2880 | 0.100 |
Why?
|
| Stress, Psychological | 1 | 2008 | 4530 | 0.100 |
Why?
|
| Abscess | 1 | 2016 | 606 | 0.100 |
Why?
|
| Blood Sedimentation | 2 | 2010 | 236 | 0.100 |
Why?
|
| Growth | 2 | 1993 | 366 | 0.100 |
Why?
|
| Mutation, Missense | 2 | 2021 | 2592 | 0.100 |
Why?
|
| Interprofessional Relations | 1 | 2018 | 997 | 0.100 |
Why?
|
| Hypoalbuminemia | 1 | 2012 | 90 | 0.100 |
Why?
|
| Recurrence | 6 | 2017 | 8509 | 0.100 |
Why?
|
| Lymphatic Metastasis | 3 | 2019 | 2914 | 0.100 |
Why?
|
| Sucrase | 1 | 2011 | 51 | 0.090 |
Why?
|
| Gastric Mucosa | 1 | 2014 | 602 | 0.090 |
Why?
|
| Drainage | 2 | 2016 | 1183 | 0.090 |
Why?
|
| Immunologic Factors | 3 | 2010 | 1596 | 0.090 |
Why?
|
| Papilloma | 1 | 1992 | 143 | 0.090 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1995 | 664 | 0.090 |
Why?
|
| alpha-Glucosidases | 1 | 2011 | 46 | 0.090 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2001 | 1512 | 0.090 |
Why?
|
| Immunity, Mucosal | 2 | 2014 | 498 | 0.090 |
Why?
|
| Lactase | 1 | 2011 | 72 | 0.090 |
Why?
|
| Delayed-Action Preparations | 1 | 2014 | 969 | 0.090 |
Why?
|
| Tuberculin Test | 1 | 2011 | 205 | 0.090 |
Why?
|
| Mutation | 3 | 2024 | 30238 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2017 | 2357 | 0.090 |
Why?
|
| Stomach | 2 | 2014 | 701 | 0.090 |
Why?
|
| Fecal Incontinence | 1 | 2013 | 246 | 0.090 |
Why?
|
| Dosage Forms | 1 | 2010 | 56 | 0.090 |
Why?
|
| Esophageal Atresia | 3 | 1989 | 226 | 0.090 |
Why?
|
| Child Health Services | 1 | 2016 | 645 | 0.090 |
Why?
|
| Carnitine | 1 | 1992 | 253 | 0.090 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2010 | 141 | 0.090 |
Why?
|
| False Negative Reactions | 1 | 2011 | 574 | 0.090 |
Why?
|
| Weight Loss | 2 | 2012 | 2721 | 0.090 |
Why?
|
| Gastric Acidity Determination | 3 | 2004 | 56 | 0.090 |
Why?
|
| Bone and Bones | 1 | 2021 | 2589 | 0.090 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 1991 | 86 | 0.090 |
Why?
|
| Animals | 25 | 2020 | 169246 | 0.090 |
Why?
|
| Cytotoxicity, Immunologic | 5 | 2001 | 1353 | 0.090 |
Why?
|
| Proportional Hazards Models | 3 | 2015 | 12543 | 0.090 |
Why?
|
| Digestion | 2 | 2017 | 53 | 0.090 |
Why?
|
| Sulfasalazine | 2 | 1993 | 85 | 0.090 |
Why?
|
| Cytoplasm | 1 | 1994 | 1505 | 0.090 |
Why?
|
| Bahamas | 1 | 2009 | 9 | 0.080 |
Why?
|
| Breath Tests | 2 | 1991 | 300 | 0.080 |
Why?
|
| Adrenal Cortex Hormones | 4 | 2014 | 1886 | 0.080 |
Why?
|
| Diagnostic Techniques, Digestive System | 1 | 2010 | 45 | 0.080 |
Why?
|
| Proctocolitis | 1 | 1990 | 31 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2022 | 2486 | 0.080 |
Why?
|
| Caseins | 1 | 2010 | 105 | 0.080 |
Why?
|
| Diet, Protein-Restricted | 1 | 2010 | 73 | 0.080 |
Why?
|
| Health Priorities | 1 | 2012 | 380 | 0.080 |
Why?
|
| Flagellin | 1 | 2010 | 124 | 0.080 |
Why?
|
| Th2 Cells | 2 | 2008 | 1078 | 0.080 |
Why?
|
| Pancreas Transplantation | 1 | 2010 | 193 | 0.080 |
Why?
|
| Th1 Cells | 2 | 2008 | 1042 | 0.080 |
Why?
|
| Perioperative Care | 1 | 2017 | 1043 | 0.080 |
Why?
|
| Aminosalicylic Acids | 3 | 2014 | 37 | 0.080 |
Why?
|
| Immunoglobulin A | 2 | 2010 | 992 | 0.080 |
Why?
|
| Medical Informatics | 1 | 2016 | 743 | 0.080 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 874 | 0.080 |
Why?
|
| Cytokines | 5 | 2013 | 7453 | 0.080 |
Why?
|
| Liver Diseases | 4 | 2010 | 1305 | 0.080 |
Why?
|
| Injections, Subcutaneous | 2 | 2001 | 687 | 0.080 |
Why?
|
| Follow-Up Studies | 11 | 2021 | 39348 | 0.080 |
Why?
|
| Membrane Glycoproteins | 1 | 1999 | 3711 | 0.080 |
Why?
|
| Enteritis | 2 | 1990 | 164 | 0.080 |
Why?
|
| Time Factors | 16 | 2017 | 40218 | 0.080 |
Why?
|
| Prospective Studies | 9 | 2018 | 54926 | 0.080 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2010 | 348 | 0.080 |
Why?
|
| Software | 2 | 2016 | 4478 | 0.080 |
Why?
|
| Middle Aged | 22 | 2019 | 223492 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 3 | 2019 | 7454 | 0.080 |
Why?
|
| History, 21st Century | 2 | 2018 | 1573 | 0.080 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2012 | 1049 | 0.080 |
Why?
|
| MicroRNAs | 2 | 2015 | 3803 | 0.070 |
Why?
|
| Autoimmune Diseases | 2 | 1991 | 2257 | 0.070 |
Why?
|
| Folic Acid Deficiency | 1 | 2008 | 117 | 0.070 |
Why?
|
| Enteral Nutrition | 1 | 2014 | 802 | 0.070 |
Why?
|
| Receptors, Growth Factor | 1 | 2009 | 324 | 0.070 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2010 | 297 | 0.070 |
Why?
|
| Serologic Tests | 1 | 2010 | 382 | 0.070 |
Why?
|
| Transplantation, Heterologous | 3 | 1992 | 2393 | 0.070 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 3436 | 0.070 |
Why?
|
| Esophageal Stenosis | 2 | 1987 | 196 | 0.070 |
Why?
|
| Permeability | 1 | 2010 | 725 | 0.070 |
Why?
|
| Interleukin-10 | 3 | 2021 | 1183 | 0.070 |
Why?
|
| Pyloric Stenosis | 1 | 1987 | 28 | 0.070 |
Why?
|
| DNA, Bacterial | 1 | 2012 | 1478 | 0.070 |
Why?
|
| Biological Products | 1 | 2017 | 948 | 0.070 |
Why?
|
| Residence Characteristics | 1 | 2017 | 2118 | 0.070 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2000 | 1441 | 0.070 |
Why?
|
| Vitamin D | 1 | 2021 | 3311 | 0.070 |
Why?
|
| Immunoglobulin G | 3 | 2014 | 4568 | 0.070 |
Why?
|
| Growth Disorders | 2 | 2008 | 635 | 0.070 |
Why?
|
| Aged, 80 and over | 8 | 2019 | 59629 | 0.070 |
Why?
|
| Life Style | 1 | 1999 | 3932 | 0.070 |
Why?
|
| Diet, Gluten-Free | 1 | 2010 | 284 | 0.070 |
Why?
|
| Surgical Staplers | 1 | 2006 | 34 | 0.070 |
Why?
|
| Agammaglobulinemia | 2 | 1985 | 174 | 0.070 |
Why?
|
| Milk | 2 | 2009 | 438 | 0.070 |
Why?
|
| Prednisone | 3 | 1991 | 1567 | 0.070 |
Why?
|
| Zenker Diverticulum | 1 | 2006 | 28 | 0.070 |
Why?
|
| Lymphocyte Activation | 6 | 2001 | 5505 | 0.070 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2010 | 892 | 0.070 |
Why?
|
| Digestive System Physiological Phenomena | 1 | 2006 | 15 | 0.070 |
Why?
|
| Radiography, Abdominal | 1 | 2010 | 541 | 0.070 |
Why?
|
| Nutrition Assessment | 1 | 2010 | 740 | 0.070 |
Why?
|
| Bile Duct Neoplasms | 1 | 1992 | 614 | 0.070 |
Why?
|
| Prognosis | 5 | 2019 | 30010 | 0.070 |
Why?
|
| Nifedipine | 1 | 1986 | 220 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 3390 | 0.070 |
Why?
|
| Collagen | 1 | 2014 | 2643 | 0.070 |
Why?
|
| Survival Rate | 3 | 2019 | 12840 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 1854 | 0.060 |
Why?
|
| Sex Distribution | 2 | 2017 | 2278 | 0.060 |
Why?
|
| Mitochondrial Diseases | 1 | 2010 | 344 | 0.060 |
Why?
|
| Growth Hormone | 1 | 2008 | 573 | 0.060 |
Why?
|
| Medical History Taking | 1 | 2010 | 779 | 0.060 |
Why?
|
| Tracheoesophageal Fistula | 1 | 1987 | 131 | 0.060 |
Why?
|
| Contrast Media | 1 | 2019 | 5330 | 0.060 |
Why?
|
| Withholding Treatment | 1 | 2010 | 620 | 0.060 |
Why?
|
| Body Composition | 2 | 2008 | 2462 | 0.060 |
Why?
|
| Postoperative Complications | 8 | 2022 | 15832 | 0.060 |
Why?
|
| Epithelium | 5 | 1992 | 1607 | 0.060 |
Why?
|
| Esophageal Achalasia | 1 | 1986 | 98 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2011 | 13014 | 0.060 |
Why?
|
| Genotype | 2 | 2018 | 13045 | 0.060 |
Why?
|
| Autoantigens | 1 | 1989 | 890 | 0.060 |
Why?
|
| Social Adjustment | 1 | 2008 | 635 | 0.060 |
Why?
|
| Age Distribution | 2 | 2017 | 2873 | 0.060 |
Why?
|
| HIV | 1 | 1992 | 1597 | 0.060 |
Why?
|
| Brazil | 1 | 2009 | 1250 | 0.060 |
Why?
|
| Organometallic Compounds | 2 | 2019 | 648 | 0.060 |
Why?
|
| Factor Analysis, Statistical | 1 | 2008 | 1001 | 0.060 |
Why?
|
| Peritoneal Neoplasms | 1 | 2011 | 714 | 0.060 |
Why?
|
| Cysts | 1 | 2010 | 685 | 0.060 |
Why?
|
| Disease Models, Animal | 5 | 2018 | 18349 | 0.060 |
Why?
|
| Histamine H1 Antagonists | 1 | 2005 | 101 | 0.060 |
Why?
|
| Child Behavior Disorders | 1 | 2010 | 812 | 0.060 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2010 | 583 | 0.060 |
Why?
|
| Adenomatous Polyposis Coli | 2 | 1999 | 219 | 0.060 |
Why?
|
| Parents | 1 | 2019 | 3595 | 0.060 |
Why?
|
| Drug Administration Schedule | 2 | 2010 | 4860 | 0.060 |
Why?
|
| Nizatidine | 1 | 2004 | 7 | 0.060 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2010 | 454 | 0.060 |
Why?
|
| Dilatation | 1 | 1986 | 311 | 0.060 |
Why?
|
| Premedication | 1 | 2005 | 246 | 0.060 |
Why?
|
| Neoplasm Staging | 3 | 2019 | 11244 | 0.060 |
Why?
|
| Esophagoplasty | 1 | 1984 | 47 | 0.060 |
Why?
|
| Age Factors | 8 | 2011 | 18412 | 0.060 |
Why?
|
| Aged | 14 | 2019 | 171504 | 0.060 |
Why?
|
| Sulfoxides | 1 | 2003 | 47 | 0.060 |
Why?
|
| Esophageal Fistula | 1 | 1984 | 60 | 0.060 |
Why?
|
| Bronchial Fistula | 1 | 1984 | 83 | 0.060 |
Why?
|
| Islets of Langerhans | 1 | 2010 | 1351 | 0.060 |
Why?
|
| Cells, Cultured | 5 | 2013 | 19015 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2010 | 9384 | 0.060 |
Why?
|
| Manometry | 4 | 2006 | 459 | 0.050 |
Why?
|
| Reperfusion Injury | 1 | 2010 | 1039 | 0.050 |
Why?
|
| Arthritis | 1 | 2009 | 684 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 6 | 2018 | 22379 | 0.050 |
Why?
|
| Patient Care Team | 2 | 2010 | 2523 | 0.050 |
Why?
|
| Incidence | 7 | 2018 | 21538 | 0.050 |
Why?
|
| Epitopes | 1 | 1989 | 2528 | 0.050 |
Why?
|
| Chemoprevention | 1 | 2005 | 327 | 0.050 |
Why?
|
| Health Education | 1 | 2010 | 1059 | 0.050 |
Why?
|
| Aging | 2 | 2015 | 8744 | 0.050 |
Why?
|
| Alleles | 2 | 2017 | 6894 | 0.050 |
Why?
|
| DNA Methylation | 2 | 2014 | 4428 | 0.050 |
Why?
|
| Genetic Testing | 2 | 2021 | 3591 | 0.050 |
Why?
|
| Hybrid Cells | 2 | 2000 | 421 | 0.050 |
Why?
|
| Body Image | 1 | 2008 | 646 | 0.050 |
Why?
|
| Injections, Intravenous | 2 | 2004 | 1377 | 0.050 |
Why?
|
| Databases, Genetic | 1 | 2010 | 1758 | 0.050 |
Why?
|
| Histamine H2 Antagonists | 1 | 2004 | 169 | 0.050 |
Why?
|
| Eosinophilia | 1 | 1987 | 556 | 0.050 |
Why?
|
| Glycogen Storage Disease Type III | 2 | 1992 | 13 | 0.050 |
Why?
|
| T-Lymphocytes | 5 | 2000 | 10266 | 0.050 |
Why?
|
| Intestinal Absorption | 1 | 2003 | 400 | 0.050 |
Why?
|
| alpha-Amylases | 1 | 2002 | 39 | 0.050 |
Why?
|
| Sensitivity and Specificity | 4 | 2010 | 14729 | 0.050 |
Why?
|
| 3' Untranslated Regions | 2 | 2015 | 515 | 0.050 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2005 | 371 | 0.050 |
Why?
|
| Folic Acid | 1 | 2008 | 1337 | 0.050 |
Why?
|
| Neutrophils | 1 | 1994 | 3786 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6526 | 0.050 |
Why?
|
| Fabaceae | 1 | 2002 | 103 | 0.050 |
Why?
|
| Cardiomyopathies | 2 | 1992 | 2056 | 0.050 |
Why?
|
| Mucins | 1 | 1985 | 570 | 0.050 |
Why?
|
| Safety | 2 | 2003 | 1159 | 0.050 |
Why?
|
| Mice, Knockout | 4 | 2018 | 14488 | 0.050 |
Why?
|
| England | 2 | 2001 | 533 | 0.050 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2003 | 423 | 0.050 |
Why?
|
| Esophageal pH Monitoring | 1 | 2022 | 203 | 0.050 |
Why?
|
| Abdomen | 1 | 1987 | 1136 | 0.050 |
Why?
|
| Azathioprine | 2 | 2014 | 354 | 0.050 |
Why?
|
| Immune Sera | 1 | 2001 | 605 | 0.050 |
Why?
|
| Lymphokines | 2 | 1983 | 924 | 0.050 |
Why?
|
| Neoplasms | 3 | 2017 | 22371 | 0.050 |
Why?
|
| Mice | 11 | 2018 | 82029 | 0.040 |
Why?
|
| United States | 9 | 2009 | 73039 | 0.040 |
Why?
|
| Robotics | 1 | 2007 | 812 | 0.040 |
Why?
|
| Hypersensitivity | 1 | 1990 | 1172 | 0.040 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 11928 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2005 | 1826 | 0.040 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2011 | 1930 | 0.040 |
Why?
|
| Genomics | 1 | 2016 | 5926 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 2001 | 624 | 0.040 |
Why?
|
| Vitiligo | 1 | 2001 | 97 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2012 | 9669 | 0.040 |
Why?
|
| Trialkyltin Compounds | 1 | 1999 | 6 | 0.040 |
Why?
|
| Killer Cells, Lymphokine-Activated | 1 | 1999 | 42 | 0.040 |
Why?
|
| Carcinoma | 1 | 2011 | 2332 | 0.040 |
Why?
|
| Steroids | 2 | 1998 | 938 | 0.040 |
Why?
|
| Developing Countries | 1 | 2012 | 2910 | 0.040 |
Why?
|
| Risk Assessment | 6 | 2017 | 24315 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 4 | 2001 | 6124 | 0.040 |
Why?
|
| Geriatrics | 1 | 2004 | 394 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1992 | 1305 | 0.040 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2007 | 1003 | 0.040 |
Why?
|
| Emigration and Immigration | 2 | 2001 | 406 | 0.040 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 1999 | 130 | 0.040 |
Why?
|
| Plant Proteins | 1 | 2002 | 376 | 0.040 |
Why?
|
| Immunophenotyping | 2 | 2001 | 1864 | 0.040 |
Why?
|
| Mice, Nude | 3 | 1992 | 3623 | 0.040 |
Why?
|
| Perforin | 1 | 1999 | 167 | 0.040 |
Why?
|
| Germany | 2 | 2015 | 883 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2022 | 18065 | 0.040 |
Why?
|
| Fas Ligand Protein | 1 | 1999 | 216 | 0.040 |
Why?
|
| Asia, Southeastern | 1 | 1999 | 115 | 0.040 |
Why?
|
| Registries | 5 | 2017 | 8375 | 0.040 |
Why?
|
| Meglumine | 1 | 2019 | 144 | 0.040 |
Why?
|
| Chemotaxis | 2 | 2013 | 600 | 0.040 |
Why?
|
| Digestive System Abnormalities | 1 | 1999 | 49 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 1999 | 525 | 0.040 |
Why?
|
| Nutritive Value | 1 | 2002 | 351 | 0.040 |
Why?
|
| Radiation Protection | 1 | 2002 | 428 | 0.040 |
Why?
|
| Hydrolysis | 1 | 1999 | 646 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 1999 | 915 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2001 | 4648 | 0.040 |
Why?
|
| Benzimidazoles | 1 | 2003 | 864 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2003 | 2230 | 0.040 |
Why?
|
| Biliary Tract Diseases | 1 | 1999 | 159 | 0.040 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2002 | 737 | 0.040 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2017 | 39 | 0.040 |
Why?
|
| Ileum | 2 | 2010 | 558 | 0.040 |
Why?
|
| Radiosurgery | 1 | 2007 | 1330 | 0.040 |
Why?
|
| Gastric Emptying | 2 | 1992 | 247 | 0.040 |
Why?
|
| Disaccharidases | 1 | 2017 | 19 | 0.040 |
Why?
|
| Cell Separation | 1 | 1983 | 1728 | 0.040 |
Why?
|
| Fertility | 1 | 2022 | 771 | 0.040 |
Why?
|
| Constriction, Pathologic | 2 | 2010 | 1104 | 0.040 |
Why?
|
| Echovirus Infections | 1 | 1977 | 7 | 0.040 |
Why?
|
| DNA, Fungal | 1 | 2018 | 275 | 0.040 |
Why?
|
| Pedigree | 2 | 2012 | 4539 | 0.040 |
Why?
|
| Melanoma | 3 | 2002 | 5706 | 0.040 |
Why?
|
| Random Allocation | 1 | 2002 | 2396 | 0.040 |
Why?
|
| Disease-Free Survival | 2 | 2005 | 6847 | 0.030 |
Why?
|
| Competency-Based Education | 1 | 1999 | 226 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2021 | 467 | 0.030 |
Why?
|
| Heart | 1 | 1990 | 4446 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2004 | 10760 | 0.030 |
Why?
|
| Nitriles | 1 | 2022 | 980 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2021 | 717 | 0.030 |
Why?
|
| Drug Tolerance | 1 | 1998 | 365 | 0.030 |
Why?
|
| Pancreatic Diseases | 1 | 1999 | 354 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2009 | 4528 | 0.030 |
Why?
|
| Drug Hypersensitivity | 1 | 2005 | 923 | 0.030 |
Why?
|
| Health | 1 | 2019 | 398 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2021 | 1194 | 0.030 |
Why?
|
| Methotrexate | 2 | 2014 | 1721 | 0.030 |
Why?
|
| Health Personnel | 1 | 2010 | 3385 | 0.030 |
Why?
|
| Cohort Studies | 8 | 2013 | 41754 | 0.030 |
Why?
|
| Gadolinium DTPA | 1 | 2019 | 823 | 0.030 |
Why?
|
| Algorithms | 3 | 2014 | 14164 | 0.030 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1999 | 528 | 0.030 |
Why?
|
| Biological Therapy | 1 | 2017 | 140 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 1999 | 2014 | 0.030 |
Why?
|
| Glycogen Debranching Enzyme System | 2 | 1992 | 5 | 0.030 |
Why?
|
| Faculty | 1 | 1999 | 383 | 0.030 |
Why?
|
| Viruses | 1 | 2019 | 373 | 0.030 |
Why?
|
| Aotus trivirgatus | 2 | 1985 | 35 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2002 | 1397 | 0.030 |
Why?
|
| Anastomosis, Surgical | 2 | 2017 | 991 | 0.030 |
Why?
|
| Hepatomegaly | 1 | 1995 | 84 | 0.030 |
Why?
|
| Fluoroimmunoassay | 1 | 1994 | 30 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1997 | 354 | 0.030 |
Why?
|
| Gastrins | 1 | 2014 | 75 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2001 | 1815 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2021 | 2661 | 0.030 |
Why?
|
| Species Specificity | 1 | 2019 | 2415 | 0.030 |
Why?
|
| Callithrix | 2 | 1985 | 95 | 0.030 |
Why?
|
| Colitis, Collagenous | 1 | 2014 | 25 | 0.030 |
Why?
|
| Genetic Association Studies | 2 | 2015 | 2744 | 0.030 |
Why?
|
| Tenascin | 1 | 2014 | 61 | 0.030 |
Why?
|
| Muscular Diseases | 2 | 1992 | 553 | 0.030 |
Why?
|
| In Situ Hybridization | 2 | 2015 | 1903 | 0.030 |
Why?
|
| RNA, Viral | 2 | 1994 | 2872 | 0.030 |
Why?
|
| Lipopolysaccharides | 2 | 2013 | 2219 | 0.030 |
Why?
|
| Saimiri | 2 | 1985 | 337 | 0.030 |
Why?
|
| Pregnancy | 3 | 2017 | 30256 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2000 | 1377 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1906 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 15454 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2013 | 2937 | 0.030 |
Why?
|
| Pancreatitis | 2 | 1992 | 1087 | 0.030 |
Why?
|
| Immunoglobulin M | 2 | 2010 | 1528 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2016 | 3671 | 0.030 |
Why?
|
| Risk Factors | 7 | 2017 | 74944 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2003 | 4249 | 0.030 |
Why?
|
| Biofeedback, Psychology | 1 | 1994 | 117 | 0.030 |
Why?
|
| Patient Care | 1 | 1999 | 629 | 0.030 |
Why?
|
| Biological Availability | 2 | 2004 | 389 | 0.030 |
Why?
|
| Leukemia | 1 | 2001 | 1519 | 0.030 |
Why?
|
| Brain | 1 | 2020 | 27360 | 0.030 |
Why?
|
| Lysine | 1 | 1997 | 1000 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 1890 | 0.030 |
Why?
|
| Macaca fascicularis | 2 | 1985 | 912 | 0.030 |
Why?
|
| Ligands | 1 | 1999 | 3284 | 0.030 |
Why?
|
| Platelet Count | 1 | 2015 | 787 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2007 | 4055 | 0.030 |
Why?
|
| Drug Resistance | 1 | 1998 | 1599 | 0.020 |
Why?
|
| Antigens, CD19 | 1 | 2015 | 446 | 0.020 |
Why?
|
| Sialorrhea | 1 | 1992 | 25 | 0.020 |
Why?
|
| Patient Selection | 2 | 2017 | 4260 | 0.020 |
Why?
|
| Pain | 1 | 1987 | 5100 | 0.020 |
Why?
|
| Nausea | 1 | 1995 | 682 | 0.020 |
Why?
|
| Transplantation, Heterotopic | 1 | 1992 | 175 | 0.020 |
Why?
|
| Bottle Feeding | 1 | 1992 | 67 | 0.020 |
Why?
|
| Kinetics | 1 | 1999 | 6329 | 0.020 |
Why?
|
| Triglycerides | 1 | 1999 | 2464 | 0.020 |
Why?
|
| Xylose | 1 | 1991 | 28 | 0.020 |
Why?
|
| SEER Program | 1 | 2017 | 1444 | 0.020 |
Why?
|
| Skin Neoplasms | 2 | 2002 | 5863 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 36743 | 0.020 |
Why?
|
| RNA Splice Sites | 1 | 2012 | 213 | 0.020 |
Why?
|
| Vomiting | 1 | 1995 | 655 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 1997 | 1191 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 863 | 0.020 |
Why?
|
| Workflow | 1 | 2016 | 860 | 0.020 |
Why?
|
| Receptors, CCR10 | 1 | 2010 | 10 | 0.020 |
Why?
|
| Body Height | 2 | 2008 | 1565 | 0.020 |
Why?
|
| Immunoglobulin J-Chains | 1 | 2010 | 26 | 0.020 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 1991 | 93 | 0.020 |
Why?
|
| Dental Prophylaxis | 1 | 2010 | 27 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1981 | 1944 | 0.020 |
Why?
|
| Jejunum | 2 | 1990 | 475 | 0.020 |
Why?
|
| Receptors, CCR | 1 | 2010 | 37 | 0.020 |
Why?
|
| Rats | 2 | 2010 | 23760 | 0.020 |
Why?
|
| Protein Stability | 1 | 2012 | 580 | 0.020 |
Why?
|
| Receptor, erbB-2 | 1 | 2021 | 2603 | 0.020 |
Why?
|
| Reimbursement Mechanisms | 1 | 2016 | 670 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2002 | 8128 | 0.020 |
Why?
|
| Porins | 1 | 2010 | 78 | 0.020 |
Why?
|
| Food, Fortified | 1 | 1992 | 189 | 0.020 |
Why?
|
| Heterozygote | 1 | 1997 | 2798 | 0.020 |
Why?
|
| Pressure | 1 | 1994 | 1172 | 0.020 |
Why?
|
| Gallbladder | 1 | 1992 | 308 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2011 | 26379 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 2013 | 12800 | 0.020 |
Why?
|
| Transplantation, Isogeneic | 1 | 2010 | 249 | 0.020 |
Why?
|
| Bacteria | 1 | 2021 | 2216 | 0.020 |
Why?
|
| Prolactin | 1 | 1992 | 627 | 0.020 |
Why?
|
| Palatine Tonsil | 1 | 2010 | 193 | 0.020 |
Why?
|
| Cyclosporine | 1 | 2012 | 777 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2018 | 2766 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2013 | 5797 | 0.020 |
Why?
|
| Genes, Homeobox | 1 | 1991 | 289 | 0.020 |
Why?
|
| Cholecystectomy | 1 | 1992 | 408 | 0.020 |
Why?
|
| Gene Expression | 2 | 2014 | 7598 | 0.020 |
Why?
|
| Metronidazole | 1 | 1991 | 236 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2001 | 11095 | 0.020 |
Why?
|
| Chemokines, CC | 1 | 2010 | 286 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2010 | 6514 | 0.020 |
Why?
|
| Autoradiography | 1 | 1990 | 727 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2013 | 582 | 0.020 |
Why?
|
| Lymphocyte Culture Test, Mixed | 4 | 1983 | 510 | 0.020 |
Why?
|
| Intestinal Fistula | 1 | 2010 | 146 | 0.020 |
Why?
|
| Thalidomide | 1 | 2014 | 886 | 0.020 |
Why?
|
| Cross-Over Studies | 2 | 2006 | 2107 | 0.020 |
Why?
|
| Tacrolimus | 1 | 2012 | 750 | 0.020 |
Why?
|
| Leukocyte Migration-Inhibitory Factors | 3 | 1983 | 11 | 0.020 |
Why?
|
| Lung | 1 | 1987 | 10099 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2002 | 3269 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 17140 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 20227 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2017 | 3556 | 0.020 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1989 | 169 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2016 | 1131 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2010 | 1162 | 0.020 |
Why?
|
| Macrophages | 1 | 1983 | 5799 | 0.020 |
Why?
|
| Anthropometry | 1 | 1993 | 1346 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2015 | 3623 | 0.020 |
Why?
|
| Ampulla of Vater | 1 | 1989 | 150 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 3948 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 2009 | 6316 | 0.020 |
Why?
|
| Hirschsprung Disease | 1 | 1990 | 163 | 0.020 |
Why?
|
| Macaca mulatta | 2 | 1985 | 2363 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 1991 | 855 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2000 | 4415 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2012 | 1836 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 1992 | 931 | 0.020 |
Why?
|
| Endocrine System | 1 | 2008 | 113 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2013 | 942 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2016 | 1523 | 0.020 |
Why?
|
| HIV Seropositivity | 1 | 1993 | 966 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1991 | 2560 | 0.020 |
Why?
|
| Pyloric Antrum | 1 | 1987 | 66 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 2815 | 0.020 |
Why?
|
| Prevalence | 1 | 2004 | 15869 | 0.020 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1994 | 1126 | 0.020 |
Why?
|
| Lymphocytes | 2 | 1987 | 2614 | 0.020 |
Why?
|
| Lactose | 1 | 1987 | 95 | 0.020 |
Why?
|
| Linear Models | 1 | 2017 | 5884 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 1997 | 6082 | 0.020 |
Why?
|
| Neutropenia | 1 | 1992 | 892 | 0.020 |
Why?
|
| Intestinal Neoplasms | 1 | 1989 | 314 | 0.020 |
Why?
|
| Organ Preservation | 1 | 2010 | 393 | 0.020 |
Why?
|
| Hematocrit | 1 | 2008 | 623 | 0.020 |
Why?
|
| Hydrogen | 1 | 1987 | 171 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 1999 | 2420 | 0.020 |
Why?
|
| Phytohemagglutinins | 2 | 1983 | 165 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 1998 | 8542 | 0.020 |
Why?
|
| Gases | 1 | 1987 | 205 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2010 | 2300 | 0.020 |
Why?
|
| Embryonic and Fetal Development | 1 | 1987 | 420 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 1994 | 6229 | 0.020 |
Why?
|
| Atrophy | 1 | 1991 | 1646 | 0.020 |
Why?
|
| Logistic Models | 2 | 2015 | 13290 | 0.020 |
Why?
|
| Equipment Safety | 1 | 2006 | 250 | 0.020 |
Why?
|
| Hypertrophy | 1 | 1987 | 562 | 0.020 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1985 | 81 | 0.020 |
Why?
|
| Genes | 1 | 1989 | 1824 | 0.020 |
Why?
|
| Microcirculation | 1 | 2010 | 1281 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1989 | 2474 | 0.020 |
Why?
|
| Curriculum | 1 | 1999 | 3782 | 0.020 |
Why?
|
| Infusions, Parenteral | 1 | 2005 | 396 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2009 | 564 | 0.010 |
Why?
|
| Nutrition Policy | 1 | 2008 | 467 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1990 | 1266 | 0.010 |
Why?
|
| Child Development | 1 | 1996 | 2330 | 0.010 |
Why?
|
| Filariasis | 1 | 1984 | 26 | 0.010 |
Why?
|
| Acute Disease | 2 | 2012 | 7243 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 4786 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 4120 | 0.010 |
Why?
|
| Transaminases | 1 | 1984 | 199 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2008 | 1156 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2009 | 1997 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 3445 | 0.010 |
Why?
|
| Spleen | 1 | 1990 | 2295 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 2004 | 363 | 0.010 |
Why?
|
| Capsules | 1 | 2004 | 193 | 0.010 |
Why?
|
| Reference Values | 1 | 2011 | 4938 | 0.010 |
Why?
|
| Esterases | 1 | 1983 | 89 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1990 | 2204 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2016 | 3620 | 0.010 |
Why?
|
| Peroxidases | 1 | 1983 | 135 | 0.010 |
Why?
|
| Intubation | 1 | 2003 | 140 | 0.010 |
Why?
|
| Zoonoses | 1 | 1984 | 180 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2021 | 23645 | 0.010 |
Why?
|
| Computational Biology | 1 | 2015 | 3568 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 12795 | 0.010 |
Why?
|
| Developmental Disabilities | 1 | 1992 | 1518 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5717 | 0.010 |
Why?
|
| Receptors, Complement | 1 | 1983 | 254 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 1987 | 1695 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 2337 | 0.010 |
Why?
|
| Immunotherapy | 1 | 1998 | 4755 | 0.010 |
Why?
|
| Dyspnea | 1 | 2010 | 1352 | 0.010 |
Why?
|
| Protein Binding | 1 | 1994 | 9343 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1991 | 2568 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1998 | 8054 | 0.010 |
Why?
|
| Leukocytes | 1 | 2010 | 2035 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1983 | 1310 | 0.010 |
Why?
|
| Administration, Intranasal | 1 | 2003 | 485 | 0.010 |
Why?
|
| Adenocarcinoma | 2 | 1989 | 6395 | 0.010 |
Why?
|
| Family | 1 | 2012 | 3209 | 0.010 |
Why?
|
| Catheterization | 1 | 1987 | 1430 | 0.010 |
Why?
|
| Probability | 1 | 2006 | 2479 | 0.010 |
Why?
|
| Diet | 2 | 2017 | 8089 | 0.010 |
Why?
|
| Antigens, T-Independent | 1 | 2000 | 20 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 2862 | 0.010 |
Why?
|
| Muscles | 3 | 1992 | 1582 | 0.010 |
Why?
|
| Radionuclide Imaging | 2 | 2002 | 2000 | 0.010 |
Why?
|
| Liver | 3 | 1992 | 7577 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 3833 | 0.010 |
Why?
|
| Deglutition Disorders | 1 | 1986 | 640 | 0.010 |
Why?
|
| New England | 1 | 2003 | 1058 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 1983 | 665 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2004 | 1534 | 0.010 |
Why?
|
| Pneumonia, Aspiration | 1 | 1981 | 145 | 0.010 |
Why?
|
| Hypersensitivity, Delayed | 2 | 1998 | 491 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2008 | 1628 | 0.010 |
Why?
|
| Digestive System Diseases | 1 | 2002 | 152 | 0.010 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1983 | 283 | 0.010 |
Why?
|
| HLA-D Antigens | 1 | 2000 | 130 | 0.010 |
Why?
|
| Graft Survival | 1 | 1991 | 3887 | 0.010 |
Why?
|
| Demography | 1 | 2005 | 1641 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 2006 | 1171 | 0.010 |
Why?
|
| Receptors, Fc | 1 | 1983 | 537 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2010 | 4194 | 0.010 |
Why?
|
| Fetal Blood | 2 | 1983 | 1361 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1985 | 1338 | 0.010 |
Why?
|
| Quality Control | 1 | 2002 | 836 | 0.010 |
Why?
|
| Asia | 1 | 2001 | 629 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 1991 | 3703 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1983 | 1081 | 0.010 |
Why?
|
| Esophageal Neoplasms | 1 | 1989 | 1668 | 0.010 |
Why?
|
| Anemia | 1 | 2008 | 1514 | 0.010 |
Why?
|
| Tyrosine | 1 | 1983 | 1427 | 0.010 |
Why?
|
| Inhalation | 1 | 1979 | 145 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2007 | 2512 | 0.010 |
Why?
|
| Cytodiagnosis | 1 | 1982 | 452 | 0.010 |
Why?
|
| Equipment Design | 1 | 2006 | 3522 | 0.010 |
Why?
|
| Antibodies | 1 | 2006 | 2421 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2010 | 2041 | 0.010 |
Why?
|
| Skin Pigmentation | 1 | 2000 | 280 | 0.010 |
Why?
|
| Data Collection | 1 | 2007 | 3327 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1985 | 1397 | 0.010 |
Why?
|
| Lymphedema | 1 | 1984 | 527 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2008 | 5902 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2010 | 3589 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2007 | 2650 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 1983 | 1418 | 0.010 |
Why?
|
| Interferons | 1 | 1980 | 720 | 0.010 |
Why?
|
| Cell Count | 1 | 2000 | 1832 | 0.010 |
Why?
|
| Lead | 1 | 2002 | 882 | 0.010 |
Why?
|
| Length of Stay | 1 | 2010 | 6498 | 0.010 |
Why?
|
| Radiography | 2 | 1984 | 6983 | 0.010 |
Why?
|
| Bone Density | 1 | 2008 | 3573 | 0.010 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2002 | 1354 | 0.010 |
Why?
|
| New York | 1 | 1977 | 882 | 0.010 |
Why?
|
| Pharynx | 1 | 1977 | 436 | 0.010 |
Why?
|
| Comorbidity | 1 | 2009 | 10590 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 1979 | 1561 | 0.010 |
Why?
|
| Artifacts | 1 | 2002 | 1926 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 1999 | 969 | 0.010 |
Why?
|
| Base Sequence | 2 | 1997 | 12421 | 0.010 |
Why?
|
| Breast Feeding | 1 | 2002 | 1363 | 0.010 |
Why?
|
| Nose | 1 | 1977 | 522 | 0.010 |
Why?
|
| Respiration | 1 | 1979 | 1665 | 0.010 |
Why?
|
| Canada | 1 | 1998 | 2130 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2005 | 8741 | 0.010 |
Why?
|
| Amylases | 1 | 1992 | 171 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1997 | 17622 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2000 | 2211 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 1994 | 659 | 0.010 |
Why?
|
| Disease Progression | 1 | 2008 | 13671 | 0.010 |
Why?
|
| Body Weight | 1 | 2002 | 4627 | 0.010 |
Why?
|
| Phenotype | 1 | 2009 | 16726 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1992 | 412 | 0.010 |
Why?
|
| Models, Biological | 1 | 1987 | 9495 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 1992 | 414 | 0.010 |
Why?
|
| DNA Probes | 1 | 1991 | 542 | 0.010 |
Why?
|
| International Cooperation | 1 | 1996 | 1436 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1991 | 1057 | 0.010 |
Why?
|
| Lipase | 1 | 1992 | 321 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1990 | 642 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2000 | 2747 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1991 | 897 | 0.000 |
Why?
|
| Alanine Transaminase | 1 | 1992 | 606 | 0.000 |
Why?
|
| Opportunistic Infections | 1 | 1992 | 375 | 0.000 |
Why?
|
| Immunoblotting | 1 | 1992 | 1647 | 0.000 |
Why?
|
| Bone Marrow Cells | 1 | 1976 | 2414 | 0.000 |
Why?
|
| Alkaline Phosphatase | 1 | 1992 | 863 | 0.000 |
Why?
|
| Bone Marrow Transplantation | 1 | 1976 | 2709 | 0.000 |
Why?
|
| Gene Library | 1 | 1991 | 1064 | 0.000 |
Why?
|
| Survival Analysis | 1 | 2000 | 10101 | 0.000 |
Why?
|
| Esophageal Diseases | 1 | 1988 | 167 | 0.000 |
Why?
|
| Pancreatic Ducts | 1 | 1989 | 330 | 0.000 |
Why?
|
| Stomach Diseases | 1 | 1988 | 134 | 0.000 |
Why?
|
| Cloning, Molecular | 1 | 1991 | 4168 | 0.000 |
Why?
|
| Mouth Diseases | 1 | 1988 | 239 | 0.000 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 1984 | 43 | 0.000 |
Why?
|
| Malta | 1 | 1984 | 6 | 0.000 |
Why?
|
| Libya | 1 | 1984 | 9 | 0.000 |
Why?
|
| Brugia | 1 | 1984 | 24 | 0.000 |
Why?
|
| Oklahoma | 1 | 1984 | 36 | 0.000 |
Why?
|
| Mitochondria, Liver | 1 | 1984 | 190 | 0.000 |
Why?
|
| Boston | 1 | 1977 | 9374 | 0.000 |
Why?
|
| Drosophila | 1 | 1991 | 1513 | 0.000 |
Why?
|
| Creatine Kinase | 1 | 1984 | 684 | 0.000 |
Why?
|
| alpha-Fetoproteins | 1 | 1983 | 229 | 0.000 |
Why?
|
| Asthma | 1 | 1981 | 6291 | 0.000 |
Why?
|
| Liver Cirrhosis | 1 | 1992 | 1960 | 0.000 |
Why?
|
| Newcastle disease virus | 1 | 1980 | 21 | 0.000 |
Why?
|
| Methionine | 1 | 1983 | 573 | 0.000 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1976 | 3626 | 0.000 |
Why?
|
| Rosette Formation | 1 | 1979 | 152 | 0.000 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 1979 | 109 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1991 | 13421 | 0.000 |
Why?
|
| Technetium | 1 | 1979 | 328 | 0.000 |
Why?
|
| Methods | 1 | 1979 | 1066 | 0.000 |
Why?
|
| Barium Sulfate | 1 | 1979 | 180 | 0.000 |
Why?
|
| Travel | 1 | 1984 | 805 | 0.000 |
Why?
|
| Graft vs Host Reaction | 1 | 1976 | 99 | 0.000 |
Why?
|
| Respiratory System | 1 | 1979 | 564 | 0.000 |
Why?
|
| Cell Line | 1 | 1989 | 15597 | 0.000 |
Why?
|
| Liver Function Tests | 1 | 1976 | 526 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1989 | 11669 | 0.000 |
Why?
|
| Transcription Factors | 1 | 1991 | 12168 | 0.000 |
Why?
|
| HLA Antigens | 1 | 1976 | 1334 | 0.000 |
Why?
|
| Transplantation, Homologous | 1 | 1976 | 4833 | 0.000 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1979 | 3114 | 0.000 |
Why?
|